Send to

Choose Destination
Dev Med Child Neurol. 1994 Jun;36(6):484-6.

Transdermal scopolamine for reduction of drooling in developmentally delayed children.

Author information

Department of Pediatrics and Neurology, US Naval Hospital, Portsmouth, VA 23708.


Ten developmentally delayed children with excessive drooling were randomized in a double-blind, placebo-controlled study to assess the efficacy and safety of transdermal scopolamine. Over half of the patients had a statistically significant reduction in drooling, and one-third had cessation of drooling, while wearing the scopolamine patch. This short-term study supports earlier reports of the safety and efficacy of transdermal scopolamine for reducing excessive drooling in developmentally disabled children.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center